Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIOSKILL: Vacc-4x therapeutic HIV vaccine with GM-CSF and romidepsin on ART
2015-003186-28Phase 2Completed
- Sponsor
- Bionor Holding
- Start
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Vacc-4x in human immunodeficiency virus infection (HIV), sponsored by Bionor Holding. Primary endpoint: Primary virologic endpoint. Started Nov 2015; status: completed.
02
Drugs
Vacc-4x
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2015-003186-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003186-28.